Cargando…
RNA Interference and MicroRNA Modulation for the Treatment of Cardiac Disorders: Status and Challenges
The current status and challenges of RNA interference (RNAi) and microRNA modulation strategies for the treatment of myocardial disorders are discussed and related to the classical gene therapeutic approaches of the past decade. Section 2 summarizes the key issues of current vector technologies whic...
Autores principales: | Poller, W., Suckau, L., Pinkert, S., Fechner, H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7121055/ http://dx.doi.org/10.1007/978-3-540-78709-9_8 |
Ejemplares similares
-
Coxsackievirus B3 and adenovirus infections of cardiac cells are efficiently inhibited by vector-mediated RNA interference targeting their common receptor
por: Fechner, H, et al.
Publicado: (2007) -
A Novel Artificial MicroRNA Expressing AAV Vector for Phospholamban Silencing in Cardiomyocytes Improves Ca(2+) Uptake into the Sarcoplasmic Reticulum
por: Größl, Tobias, et al.
Publicado: (2014) -
Pharmacological and Biological Antiviral Therapeutics for Cardiac Coxsackievirus Infections
por: Fechner, Henry, et al.
Publicado: (2011) -
Cardiac-targeted delivery of regulatory RNA molecules and genes for the treatment of heart failure
por: Poller, Wolfgang, et al.
Publicado: (2010) -
Inhibition of coxsackievirus B3 by RNA interference (RNAi)
por: Kurreck, J, et al.
Publicado: (2006)